Policymakers and Payers

This document provides an overview of essential information necessary for understanding mental health and substance use disorder parity and how to implement and comply with federal parity laws.

These organizational action items empower prevention professionals to incorporate anti-racism into the operational practices and community outcomes of their substance use prevention work.

This virtual five-part learning community is for prevention professionals working in communities of color. It discusses best practices for delivering culturally competent services, prevention’s role in eliminating systemic and structural barriers to wellness, substance use disorder, and much more.

This handout is designed to assist both newly formed and seasoned prevention coalitions to determine the who, what, and how to reduce health disparities as they implement substance misuse prevention programs.

Part 2 of this two-part series features a panel presentation of experts discussing how and why the system of inequity exists. Panelists share the fundamental causes of health disparities and recommendations to the field on responding to health disparities in substance misuse prevention.

Part 1 of this two-part series begins to explore why health equity matters in prevention, and uncover how culture and personal bias influence substance misuse prevention work.

This compilation of best practice recommendations and resources provides guidance to initiate and expand MAT programs for OUD for patient populations in a variety of service settings.

This report is intended to support state Medicaid agencies and payers in improving access to substance use disorder treatment, quality, and capacity, with a special focus on medication-assisted treatment for opioid use disorder.

This report explores the use of Value-Based Payment model and the potential to improve delivery of integrated and coordinated substance use disorder treatment services. This page also includes the webinar slides and recording from the presentation on this report.

This guide focuses on using medication-assisted treatment for opioid use disorder in jails and prisons and during the reentry process when justice-involved persons return to the community.